These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23589672)

  • 1. Interleukin-7 promotes HIV persistence during antiretroviral therapy.
    Vandergeeten C; Fromentin R; DaFonseca S; Lawani MB; Sereti I; Lederman MM; Ramgopal M; Routy JP; Sékaly RP; Chomont N
    Blood; 2013 May; 121(21):4321-9. PubMed ID: 23589672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
    Iglesias-Ussel M; Vandergeeten C; Marchionni L; Chomont N; Romerio F
    J Virol; 2013 Aug; 87(16):9148-58. PubMed ID: 23760244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure.
    Goonetilleke N; Clutton G; Swanstrom R; Joseph SB
    Front Immunol; 2019; 10():1966. PubMed ID: 31507594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
    Fromentin R; Bakeman W; Lawani MB; Khoury G; Hartogensis W; DaFonseca S; Killian M; Epling L; Hoh R; Sinclair E; Hecht FM; Bacchetti P; Deeks SG; Lewin SR; Sékaly RP; Chomont N
    PLoS Pathog; 2016 Jul; 12(7):e1005761. PubMed ID: 27415008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
    Elliott JH; Wightman F; Solomon A; Ghneim K; Ahlers J; Cameron MJ; Smith MZ; Spelman T; McMahon J; Velayudham P; Brown G; Roney J; Watson J; Prince MH; Hoy JF; Chomont N; Fromentin R; Procopio FA; Zeidan J; Palmer S; Odevall L; Johnstone RW; Martin BP; Sinclair E; Deeks SG; Hazuda DJ; Cameron PU; Sékaly RP; Lewin SR
    PLoS Pathog; 2014 Oct; 10(10):e1004473. PubMed ID: 25393648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4
    Roche M; Tumpach C; Symons J; Gartner M; Anderson JL; Khoury G; Cashin K; Cameron PU; Churchill MJ; Deeks SG; Gorry PR; Lewin SR
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
    Vandergeeten C; Fromentin R; Chomont N
    Cytokine Growth Factor Rev; 2012; 23(4-5):143-9. PubMed ID: 22743037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Latent Reservoir for HIV-1.
    Sengupta S; Siliciano RF
    Immunity; 2018 May; 48(5):872-895. PubMed ID: 29768175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence.
    Murray AJ; Kwon KJ; Farber DL; Siliciano RF
    J Immunol; 2016 Jul; 197(2):407-17. PubMed ID: 27382129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 reservoir dynamics in CD4+ T cells.
    Bruner KM; Cohn LB
    Curr Opin HIV AIDS; 2019 Mar; 14(2):108-114. PubMed ID: 30531293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
    Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC
    PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.